Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis

Title
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 945, Issue -, Pages 175613
Publisher
Elsevier BV
Online
2023-02-24
DOI
10.1016/j.ejphar.2023.175613

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search